Ranbaxy Laboratories on Thursday launched a generic version of Prasugrel, used in treating heart diseases, from Daiichi Sankyo portfolio in India as part of strategy to launch drugs from the parent......
Bogged down by a huge foreign exchange loss, pharma major Ranbaxy Laboratories today reported a sharp decline of 48.2 per cent in its profit after tax to $72 million (Rs 332 crore) for its second......